Evidence map›Paper›PMID 33250766›Full record

ArticleFrontiers in pharmacology2020

A Network Pharmacology Approach to Investigate the Anticancer Mechanism and Potential Active Ingredients of

Qing Zhang, Jia Liu, Ruolan Li, Rong Zhao, Mengmeng Zhang, Shujun Wei, Dong Ran, Wei Jin, Chunjie Wu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Bioactive Potential ofPlants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. [Therapeutic mechanism of emodin for treatment of rheumatoid arthritis: a network pharmacology-based analysis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Qing ZhangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jia LiuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ruolan LiSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Rong ZhaoSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Mengmeng ZhangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Shujun WeiEmergency Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Dong RanSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Wei JinEmergency Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chunjie WuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosislung cancernetwork pharmacologyRheum palmatum L. (Dahuang)traditional Chinese medicine

Identifiers

PMID33250766
PMCPMC7672213
OpenAlexW3097908825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.